Bart A. Frizzell, MD
- Associate Professor, Radiation Oncology (Winston-Salem)

Bart A. Frizzell, MD
- Associate Professor, Radiation Oncology (Winston-Salem)
Research Interests
- Prostate Cancer
- Prostate Brachytherapy
- Bladder Cancer
- Head and Neck Cancer
- Education
- MD, University of Tennessee Health Science Center College of Medicine, 1996
- Internship
- Transitional Year, Methodist Central Hospital, 1997
- Residency
- Radiation Oncology, Medical University of South Carolina Medical Center, 2001
- Board Certifications
- American Board of Radiolog, American Board of Radiology
- American Board of Radiology, American Board of Radiology
- American Board of Radiology, Radiation Oncology
- American Board of Radiology - Radiation Oncology
- Positions
- Associate Professor, Radiation Oncology (Winston-Salem)
- Associate Professor, Urology (Winston-Salem)
- Departments and Affiliations
- Radiation Oncology (Winston-Salem)
- Urology (Winston-Salem)
- Comprehensive Cancer Center (CCC)
Research
- A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG. Int. J. Radiat. Oncol. Biol. Phys. 2007 Dec; 69(5):1496-501.
- Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer. Frizzell B, Sinha D, Williams T, Reed CE, Sherman CA, Turrisi A. Am. J. Clin. Oncol. 2003 Jun; 26(3):215-20.
- Management of treatment-resistant cutaneous sarcoidosis with radiation. Frizzell B, Stith M, Jenrette J. Am. J. Clin. Oncol. 2002 Dec; 25(6):573-5.
- Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma. Shenker RF, May NH, Waltonen JD, Yang JP, O'Neill SS, Frizzell BA, Greven KM, Hughes RT. Head Neck Pathol. 2021 Feb;
- Perineural Invasion As the Sole Pathologic Risk Factor After Surgical Resection for Head and Neck Squamous Cell Carcinoma. Hughes RT, Farris J, Steber C, Frizzell BA, Greven KM. Cureus. 2021 Feb; 13(2):e13094.